DLL3 (Rovalpituzumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7607828

The Humanized Monoclonal anti-DLL3 (Rovalpituzumab Biosimilar) antibody has been validated for FACS and ELISA. It is suitable to detect DLL3 (Rovalpituzumab Biosimilar) in samples from Human.

Quick Overview for DLL3 (Rovalpituzumab Biosimilar) antibody (Biotin) (ABIN7607828)

Target: DLL3 (Rovalpituzumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This DLL3 (Rovalpituzumab Biosimilar) antibody is conjugated to Biotin

Application: Flow Cytometry (FACS), ELISA

Product Details anti-DLL3 (Rovalpituzumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-DLL3(Rovalpituzumab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Target Details for DLL3 (Rovalpituzumab Biosimilar)

Target: DLL3 (Rovalpituzumab Biosimilar)

Alternative Name: Rovalpituzumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:SCDO1
Synonyms Antibody:SC0001-SCX,SC0002,sc0001-SCX